Everyone who came to the MOY shopping center in Khimki on January 26 got a chance to have an unforgettable experience piloting a race car along a real race track at the professional racing platform set up by the Capital Racing Team Esports racing school.
Back to the list of publications
Bosnalijek and FC Grand Capital are developing their partnership
15 october 2024
Bosnalijek, a Bosnian pharma company, producer of well-known drugs like Lyzobact, Enterofuril and Bronchobos, Russian distributor FC Grand Capital and Innova Pharm Centre for Strategic Partnerships held a strategic partnership development session on October 15, 2024 in Istanbul. Leaders of the three companies discussed the results of their interactions at the Russian market in 2024, their plans and targets for 2025, as well as prospects further down the road.
In the early 2024, Bosnalijek and FC Grand Capital signed a contract to supply the entire range of the Bosnian company's products to the Russian market.
At the meeting, the parties reaffirmed their intention to expand their partnership in 2025, allowing Bosnalijek's presence at the Russian market to grow and the portfolio of their products available to Russian consumers to expand using FC Grand Capital's distributing capabilities.
* Bosnalijek Pharma was founded in Sarajevo (Bosnia and Herzegovina) in 1951. The company has been producing medicines for oral, parenteral and external application for 70 years. Bosnalijek's portfolio today includes over 160 drugs based on 83 generic substances used in key healthcare areas: neurology, cardiology, pediatrics, gastroenterology, ENT and dermatology.
*FC Grand Capital is a top 5 national pharma distributor in Russia; for several years, the company used to be among the top 50 fastest growing Russian companies.
The Company's mission is to provide quality medicines to the population and to develop Russia's pharma market.
FC Grand Capital uses the most advanced marketing, logistics and management technologies focused on becoming the best distribution company that cares for people's health.
The Company's portfolio includes 10,000 products by 400 leading Russian and foreign manufacturers.
FC Grand Capital's reputation is bidding, both at government and commercial level, is unimpeachable.
The company's client base includes 48,000 points of sale: from large chains to small corner pharmacies.
FC Grand Capital has resources to set up logistics processes of any complexity. The Company has over 60,000 square meters of warehousing space with modern equipment and vehicles.
Logistics depots are located in:
Moscow, Vladivostok, Volgograd, Voronezh, Yekaterinburg, Kaliningrad, Kirov, Krasnodar, Krasnoyarsk, Novosibirsk, Saint Petersburg, Tyumen, Cheboksary.
The Company employs over 1,500 people in its various business segments.
FC Grand Capital pharma distributor was founded in Moscow in 2002.
* Innova Pharm Centre for Strategic Partnerships: the InnovaPharm ecosystem provides full 360º promotion programs for the entire product chain.
24 september 2024
FC Grand Capital Director for Public Procurement Development talks about the company's results and perspectives at the government contract market